Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro

https://doi.org/10.1016/S0014-2999(98)00730-4Get rights and content

Abstract

Previous work has been carried out on the effects of adenosine on transmitter release and on the excitability of postsynaptic neurones, but little is known about the effects of adenosine on the coupling between the two. In this study, we examine the effects of specific adenosine receptor agonists and antagonists on the population excitatory postsynaptic potential (population EPSP) slope, the population spike amplitude, and the relationship between the two (ES coupling) in the CA1 area of rat hippocampus. Activation of adenosine A1 receptors by adenosine or the selective agonist N6-cyclopentyladenosine resulted in a decrease of the population spike amplitude by a greater extent than could be accounted for by the decrease in population EPSP slope, resulting in a dissociation in the ES relationship, reflected as a right-shift in the ES curve. Activation of adenosine A2A receptors by the selective agonist 2-p-(2-carboxyethy)phenethylamino-5′-N-ethylcarboxamidoadenosine (CGS 21680), or blockade by antagonists ZM 241385 and CP 66713 had no effect on evoked responses. However, when both adenosine A1 and A2A receptors were activated at the same time, a significant attenuation of the inhibitory effects of N6-cyclopentyladenosine on population spike amplitude was observed, resulting in a left-shift in the ES curve. Intracellular recording indicated that N6-cyclopentyladenosine raised the threshold for spike induction by pulses of depolarising current, even at a concentration which did not produce hyperpolarisation of the neurone. At 30 nM, CGS 21680 prevented this effect of N6-cyclopentyladenosine, and this apparent antagonism was prevented by the A2A receptor antagonist ZM 241385. The results show that adenosine A1 receptors change the coupling between presynaptic transmitter release and postsynaptic cell firing, and that this effect is attenuated by A2A receptor activation.

Introduction

Adenosine is a neuromodulator with both presynaptic and postsynaptic effects in the mammalian central nervous system (CNS). It has been suggested that these effects are mediated by different mechanisms in view of, for example, their different sensitivities to agents such as pertussis toxin (Fredholm et al., 1989; Hasuo et al., 1992; Thompson et al., 1992). Presynaptically, adenosine has been shown to inhibit the release of neurotransmitters such as acetylcholine (Spignoli et al., 1984; Cunha et al., 1994b), dopamine (Michaelis et al., 1979; Zetterstrom and Fillenz, 1990), serotonin (Feuerstein et al., 1985), and glutamate (Fastbom and Fredholm, 1985). The mechanism of adenosine's presynaptic effects is not fully clear but it has been suggested that it causes an increase in potassium conductance which could hyperpolarise the axon terminal and so prevent transmitter release (Thompson et al., 1992). Supporting this, it has been shown that K+ channel blockers such as 4-aminopyridine can reduce the effects of adenosine (Stone, 1981). An indirect decrease of Ca2+ currents or intracellular Ca2+ levels by this adenosine activated potassium conductance has also been suggested as a mechanism of presynaptic inhibition (Dunwiddie and Haas, 1985; Michaelis et al., 1988). Alternatively, adenosine may exert its presynaptic effects by inhibiting Ca2+ influx directly (Dolphin et al., 1986; Schubert et al., 1987).

Postsynaptically, the mechanism of action of adenosine is clearer. Several groups have suggested that adenosine causes an increase in outward potassium conductance leading to a hyperpolarisation of the postsynaptic membrane (Okada and Ozawa, 1980; Segal, 1982; Trussel and Jackson, 1985). This potassium conductance has been shown to be both Ca2+ and voltage insensitive in CA1 neurones (Gerber et al., 1989).

Earlier studies have suggested that the inhibitory presynaptic actions and postsynaptic hyperpolarising actions of adenosine are mediated by A1 receptors (Dunwiddie and Fredholm, 1989; Alzheimer et al., 1991; Ameri and Jurna, 1991; Lambert and Teyler, 1991; Hasuo et al., 1992) which are present in high density in the hippocampus, especially in the CA1 region (Fastbom et al., 1987). Electrophysiological (Sebastião and Ribeiro, 1992) and binding (Jarvis et al., 1989; Cunha et al., 1994a) studies have shown that adenosine A2A receptors are also present in the hippocampus but conflicting reports exist as to the functional importance of these receptors and their ability to interact with adenosine A1 receptors. Cunha et al. (1994a) describe an attenuation of the inhibitory effects on population spike amplitude caused by activation of A1 adenosine receptors with N6-cyclopentyladenosine in the presence of the selective A2A adenosine receptor agonist 2-p-(2-carboxyethy)phenethylamino-5′-N-ethylcarboxamidoadenosine (CGS 21680) in the rat hippocampus. In contrast, Dunwiddie et al. (1997) report that pre-treatment of hippocampal slices with CGS 21680 had no effect on subsequent responses to adenosine. Recently, Dixon et al. (1997) have shown the appearance of a low-affinity binding site for the adenosine A1 receptor agonist 2-chloro-N-6-cyclopentyladenosine in the rat striatum caused by incubation of striatal synaptosomes with CGS 21680.

Although the aforementioned pre- and postsynaptic effects of adenosine have been well-characterised, little work has been carried out with regard to the effects of adenosine on the coupling between the two. This study investigates the effects of adenosine receptor agonists and antagonists on the population excitatory postsynaptic potential, the population spike, and the relationship between them i.e., EPSP–spike (ES) coupling. The population excitatory postsynaptic potential (population EPSP) gives primarily a measure of membrane potential changes generated by excitatory synapses on the apical dendrites of CA1 pyramidal neurones. This extracellularly recorded potential has been shown to be affected by adenosine in the same way as intracellularly recorded EPSPs from the same cells (Proctor and Dunwiddie, 1987). The population spike reflects the summated firing of CA1 pyramidal neurones (Andersen et al., 1971) and gives a measure of the excitability of the postsynaptic neurone. ES coupling gives an indication of the ability of a given level of synaptic depolarisation to induce the postsynaptic cell to fire an action potential. The three parameters measured can vary independently, and a description of all three is necessary to provide a full analysis of agents on neuronal function.

Section snippets

Method

Male Wistar rats (150–250 g) were anaesthetised with urethane (1.5 g/kg) i.p. and cooled on ice while breathing oxygen-enriched air until rectal temperature reached 30°C. This procedure was recommended by Newman et al. (1992) to enhance the viability of slices. The animals were then killed by cervical dislocation, decapitated, and the brain rapidly removed to ice-cold artificial cerebrospinal fluid (aCSF) of composition (mmol/l) KH2PO4 2.2, KCl 2, NaHCO3 25, NaCl 115, CaCl2 2.5, MgSO4 1.2,

Adenosine

The relationship between stimulation strength and population EPSP slope, population spike amplitude, and the corresponding ES curve are summarised for a typical slice in Fig. 1. The addition of adenosine at 20 μM in this case resulted in a significant decrease in both the population EPSP slope and population spike amplitude. From the population of slices examined, adenosine at 50 μM decreased both the population EPSP slope and population spike amplitude significantly (n=5, p<0.01 and p<0.001,

Discussion

The results reveal that adenosine reduces both the population EPSP slope and population spike amplitude in the CA1 area of rat hippocampus, showing that it has both pre- and postsynaptic actions. Consistent with previous findings (Dunwiddie and Fredholm, 1989; Alzheimer et al., 1991; Lambert and Teyler, 1991), these effects are mediated by adenosine A1 receptors as shown by the fact that the selective A1 agonist N6-cyclopentyladenosine produced a similar depression of both potentials while the A

Acknowledgements

EMOK is a recipient of a Glasgow University IBLS scholarship. We are grateful to Dr. Poucher of Zeneca Pharmaceuticals for the gift of ZM 241385.

References (54)

  • H. Hasuo et al.

    Adenosine inhibits the synaptic potentials in rat septal nucleus neurons mediated through pre- and postsynaptic A1-adenosine receptors

    Neurosci. Res.

    (1992)
  • G. Hess et al.

    Changes in field excitatory postsynaptic potential shape induced by tetanization in the CA1 region of the guinea-pig hippocampal slice

    Neuroscience

    (1990)
  • N.A. Lambert et al.

    Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus

    Neurosci. Lett.

    (1991)
  • M.L. Michaelis et al.

    Studies on the ionic mechanisms for the neuromodulatory actions of adenosine in the brain

    Brain Res.

    (1988)
  • M.L. Michaelis et al.

    Adenosine modulation of synaptosomal dopamine release

    Life Sci.

    (1979)
  • G.C. Newman et al.

    Preservation of hippocampal brain slices with in vivo or in vitro hypothermia

    Brain Res.

    (1992)
  • M.H. O'Regan et al.

    The selective A2 adenosine agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischaemic rat cerebral cortex

    Neurosci. Lett.

    (1992)
  • W.R. Proctor et al.

    Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus

    Brain Res.

    (1987)
  • P. Schubert

    Physiological modulation by adenosine: selective blockade of A1-receptors with DPCPX enhances stimulus train-evoked neuronal calcium influx in rat hippocampal slices

    Brain Res.

    (1988)
  • A.M. Sebastião et al.

    Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus

    Neurosci. Lett.

    (1992)
  • M. Segal

    Intracellular analysis of a postsynaptic action of adenosine in the rat hippocampus

    Eur. J. Pharmacol.

    (1982)
  • G. Spignoli et al.

    A1 and A2 adenosine receptors modulate acetylcholine release from brain slices

    Eur. J. Pharmacol.

    (1984)
  • R.A. Tomasulo et al.

    LTP-associated EPSP/spike dissociation in the dentate gyrus: GABAergic and non-GABAergic components

    Brain Res.

    (1991)
  • T. Zetterstrom et al.

    Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release

    Eur. J. Pharmacol.

    (1990)
  • P. Andersen et al.

    Unit analysis of the hippocampal population spike

    Exp. Brain Res.

    (1971)
  • P. Andersen et al.

    Possible mechanisms for long-lasting potentiation of synaptic transmission in hippocampal slices from guinea-pigs

    J. Physiol.

    (1980)
  • C. Bernard et al.

    Expression of EPSP/spike potentiation following low frequency and tetanic stimulation in the CA1 area of the rat hippocampus

    J. Neurosci.

    (1995)
  • Cited by (74)

    • Purinergic signalling in brain ischemia

      2016, Neuropharmacology
      Citation Excerpt :

      The ability of adenosine A2A receptor antagonists in protecting against ischemic damage is largely attributed to the control of excessive glutamatergic transmission and of the ensuing acute excitoxicity after ischemia. A2A receptors play in fact an important modulation of synaptic transmission (Lopes et al., 2011; Sebastião and Ribeiro, 1996) as mostly demonstrated in the hippocampus (Cunha et al., 1994; Lopes et al., 1999; O'Kane and Stone, 1998) and counteract depression brought about by A1 receptor. In the CA1 area of the rat hippocampus, the selective A2A receptor agonist, 2-p-(2-carboxyethyl)phenethylamino-5′-Nethylcarboxamidoadenosine hydrochloride (CGS21680), clearly reduces the OGD induced-depression of synaptic activity (Latini et al., 1999a).

    • Protein kinase A mediates adenosine A<inf>2a</inf> receptor modulation of neurotransmitter release via synapsin I phosphorylation in cultured cells from medulla oblongata

      2014, Neuroscience Research
      Citation Excerpt :

      Moreover, CGS 21680 inhibits GLU uptake in primary cultured astrocytes, which might contribute to increased GLU levels (Matos et al., 2012). Previous works have shown that A2aR may activate different intracellular transduction pathways via cross talk, e.g., protein kinase C (O’Kane and Stone, 1998; Lopes et al., 1999). Therefore investigate which transduction pathways take place during A2aR activation is very important to disclose events of neurotransmission modulation and, subsequently, the physiological relevance of the phenomenon.

    • Adenosine receptors in cerebral ischemia

      2014, International Review of Neurobiology
      Citation Excerpt :

      A2A receptors in the striatum are mostly present on GABA–enkephalin neurons (Schiffmann, Jacobs, & Vanderhaeghen, 1991) but are also located presynaptically on glutamatergic terminals (Hettinger et al., 2001; Rosin, Hettinger, Lee, & Linden, 2003), where they can directly regulate glutamate outflow (Marcoli et al., 2004, 2003). Under in vitro OGD, A2A receptors play an important modulation of synaptic transmission (Lopes, Sebastião, & Ribeiro, 2011; Sebastião & Ribeiro, 1996) as mostly demonstrated in the hippocampus (Cunha et al., 1994; Lopes, Cunha, & Ribeiro, 1999; O'Kane & Stone, 1998). In the CA1 area of the rat hippocampus, which is a most sensitive region to ischemia, the selective A2A agonist, CGS21680, clearly reduces the depression of synaptic activity brought about by OGD (Latini, Bordoni, Corradetti, Pepeu, & Pedata, 1999).

    • Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies

      2011, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      Furthermore, A2AR activation can trigger alternative signaling pathways via interaction with other receptors and signaling molecules. For instance, A2AR heterodimer and/or functional interactions with A1Rs [38–40], dopamine D2 receptors (D2Rs) [41,42], group I metabotropic glutamate 5 receptors (mGlu5Rs) [43,44], N-methyl-d-aspartate receptors (NMDARs) [40,45], and cannabinoid CB1 receptors (CB1Rs) [46,47] have been reported. A2ARs have also been noted by in vitro assays and/or electrophysiology to affect signaling through brain-derived neurotrophic factor (BDNF) in hippocampus [48,49] and fibroblast growth factor (FGF) as well as glial cell line-derived neurotrophic factor in striatum [50] to modulate synaptic transmission.

    View all citing articles on Scopus
    View full text